AzTrials
AzTrials

Major Depressive EpisodeNCT04899609

The Effects of Anger and Joy Expressions on Approach and Avoidance Behaviors in Healthy Volunteers

An observational study of Major Depressive Episode, run by University Hospital, Montpellier at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Social interactions are part of our daily lives. Communicating with others is a recurring choice which is based on emotional cues, such as facial expression. Our action must be adapted to the emotional state of our interlocutor, otherwise the investigators will have poor quality interactions An emotional stimulus… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Major Depressive Episode
How many people
40 participants
Where
1 siteFrance
Study dates
1 Jun 2021to 30 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy volunteers

Who may be able to join

  • Being between 18 and 65 years old
  • Absence of psychiatric pathology over the entire life
  • Being able to understand the nature, purpose and methodology of the study

Who cannot join

  • Mental retardation or sever medical co-morbidity
  • Sensory or cognitive disability
  • Pregnant or breastfeeding woman
  • Protection by law (guardianship or curatorship)
  • Deprivation of liberty (by judicial or administrative decision)
  • Inability to understand, speak and write French

Trial locations and contacts

1 site in 1 country.

Nathan RISCH, MD (intern) contact

risch.nathan@gmail.com

France1 site, 1 recruiting
  • University hospital

    Montpellier, 34295

    Emilie OLIE, MD PhD, 4 67 33 82 89 ext. 33, e-olie@chu-montpellier.fr

    Myriam BENRAMDANE, 4 99 61 45 75 ext. 33, m-benramdane@chu-montpellier.fr

    Recruiting

Other trials in France

About this study

Official title: Behavioral Adaptation to Negative and Positive Social Signals in Healthy Volunteers

Social interactions are part of our daily lives. Communicating with others is a recurring choice which is based on emotional cues, such as facial expression. Our action must be adapted to the emotional state of our interlocutor, otherwise the investigators will have poor quality interactions An emotional stimulus would cause a conditioned response (innate reaction). Thus, the presence of an angry person would automatically trigger flight behavior. More recently, however, it has been envisioned that this same avoidance behavior could be the result of a goal-directed behvior. In this case, the avoidance behavior would be the result of an evaluation of the consequences of the selected action. These goal-directed behaviors are guided by a mental representation of consequences The project aims to study behavioral choices (approach and avoidance) in response to negative and positive social cues (anger and joy) in 40 healthy volunteers using a computerized neuropsychological task, and to determine wheter these choices are the result of goal-directed behavior.

The study also aims to assess the modulation of behavioral adaptation by the level of impulsivity, lonilness, empathy, and by the capcity to understand others' intenstions.

Keywords
Emotion, Motivation, Decision making, Goal-director behavior

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of approach and avoidance behavior in response to positive (joy) and negative (anger) social signals

    Calculation of the proportion of avoidance vs. approach choices

    Measured: 1 day

Secondary outcomes (1)
  1. Response time

    Computerized measurement of reaction time before clicking to make the avoidance or approach choice

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2021
  2. Study start1 Jun 2021
  3. Primary completion1 Jun 2022 (estimated)
  4. Study completion30 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04899609
Sponsor's protocol ID
RECHMPL21_0304
Status last verified
Sep 2021
First submitted
18 May 2021
Last updated
8 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Questions about this trial

What is this clinical trial studying?

An observational study of Major Depressive Episode, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Emilie Olie, MD PhD (+33 4 67 33 85 81, e-olie@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of approach and avoidance behavior in response to positive (joy) and negative (anger) social signals (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in